SCHEMBL4602768

SCHEMBL4602768

CCOc1ccc(-c2cccc(N3CCCC3)c2)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 3/20 0.50
FFAR4 Q5NUL3 1/20 0.49
TSHR P16473 2/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
RAB9A P51151 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CREBBP Q92793 1/20 0.48
MRGPRX4 Q96LA9 2/20 0.48
FFAR1 O14842 1/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALOX15 P16050 1/20 0.46
KCNB1 Q14721 1/20 0.46
MAPT P10636 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4600417 0.81 PTPN11 (0.60) PTPN11TSHRLMNAMRGPRX4KMT2A
SCHEMBL4603368 0.80 PTPN11 (0.59) PTPN11TSHRLMNAKMT2AALDH1A1
SCHEMBL2771810 0.80 CFD (0.61) PTPN11TSHRLMNAKMT2AALDH1A1
SCHEMBL5149300 0.78 PTPN11 (0.76) PTPN11TSHRLMNACREBBPMRGPRX4
SCHEMBL4601409 0.78 PTPN11 (0.57) PTPN11TSHRLMNAKMT2AHSD17B10
SCHEMBL4602172 0.77 PTPN11 (0.56) PTPN11TSHRLMNAKMT2AHSD17B10
SCHEMBL4602328 0.77 PTPN11 (0.56) PTPN11TSHRLMNASMN1; SMN2RAB9A
SCHEMBL4601902 0.76 ACMSD (0.62) PTPN11TSHRMRGPRX4KMT2AHSD17B10
SCHEMBL3933361 0.76 RXRA (0.57) PTPN11FFAR4TSHRLMNANPSR1
SCHEMBL5151569 0.76 PTPN11 (0.65) PTPN11LMNACREBBPKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO claimed
EP-1912970-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL Bayer Schering Pharma Aktiengesellschaft (DE) 2008-04-23 EP disclosed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
WO-2007017289-A2 ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R PTPN11 3529/4885FFAR4 354/4885TSHR 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.